We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioquell | LSE:BQE | London | Ordinary Share | GB0004992003 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 597.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMBQE
RNS Number : 6226K
Bioquell PLC
17 April 2015
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION
17 April 2015
Bioquell PLC
("Bioquell" or the "Company")
Publication of Circular
Further to the announcement made by the Company on 12 March 2015 with respect to the proposed disposal of TRaC Global Limited to Element Materials Technology Group Holdings Limited (the "Disposal"), the Board of Bioquell is pleased to announce that a shareholder circular relating to the Disposal (the "Circular") has been approved by the UK Listing Authority. The Circular contains further details on the Disposal and a notice convening a general meeting of the Company to be held at the offices of Ashurst LLP, Broadwalk House, 5 Appold Street, London EC2A 2HA at 3.00p.m. on 5 May 2015 to seek shareholder approval for the Disposal. The Circular together with the form of proxy for the General Meeting has been published and is being posted to Shareholders today.
A copy of the Circular and the accompanying form of proxy has also been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM. In addition, the Circular will be available to view on the Company's website (www.bioquellplc.com) and available for inspection during normal business hours on any weekday at the offices of the Company at 52 Royce Close, West Portway, Andover, Hampshire SP10 3TS and at the offices of Ashurst LLP, Broadwalk House, 5 Appold Street, London EC2A 2HA.
For further information, contact:
01264 835 Bioquell PLC 900 Nigel Keen Chairman Nick Adams Chief Executive Michael Roller Finance Director Investec Bank plc (Sponsor, Financial Adviser and Corporate Broker to Bioquell) 020 7597 4000 Keith Anderson Daniel Adams Ben Williams Citigate Dewe Rogerson (Financial PR Adviser to Bioquell) 020 7638 9571 Malcolm Robertson
This announcement has been issued by, and is the sole responsibility of, Bioquell.
Investec Bank plc ("Investec"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the Financial Conduct Authority and the PRA, is acting exclusively for Bioquell in relation to the Disposal. Investec is not acting for any other person and Investec will not be responsible to any person other than Bioquell for providing the protections afforded to clients of Investec or for providing advice in relation to the Disposal or in relation to the contents of or any transaction or arrangement referred to in this announcement.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOEEDLFFEZFBBBV
1 Year Bioquell Chart |
1 Month Bioquell Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions